• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    General Counsel and Corp Sec Mcgrane Ashley converted options into 1,317 shares, covered exercise/tax liability with 388 shares and sold $50,483 worth of shares (5,270 units at $9.58), decreasing direct ownership by 19% to 19,121 units (SEC Form 4)

    6/3/25 4:16:35 PM ET
    $ZI
    Computer Software: Prepackaged Software
    Technology
    Get the next $ZI alert in real time by email
    SEC FORM 4 SEC Form 4
    FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

    Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
    or Section 30(h) of the Investment Company Act of 1940
    OMB APPROVAL
    OMB Number: 3235-0287
    Estimated average burden
    hours per response: 0.5
      
    Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
    X
    Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
    1. Name and Address of Reporting Person*
    McGrane Ashley

    (Last) (First) (Middle)
    C/O ZOOMINFO TECHNOLOGIES INC.,
    805 BROADWAY STREET, SUITE 900

    (Street)
    VANCOUVER WA 98660

    (City) (State) (Zip)
    2. Issuer Name and Ticker or Trading Symbol
    ZoomInfo Technologies Inc. [ GTM ]
    5. Relationship of Reporting Person(s) to Issuer
    (Check all applicable)
    Director 10% Owner
    X Officer (give title below) Other (specify below)
    General Counsel and Corp Sec
    3. Date of Earliest Transaction (Month/Day/Year)
    05/30/2025
    4. If Amendment, Date of Original Filed (Month/Day/Year)
    6. Individual or Joint/Group Filing (Check Applicable Line)
    X Form filed by One Reporting Person
    Form filed by More than One Reporting Person
    Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
    1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V Amount (A) or (D) Price
    Common Stock 06/01/2025 M(1) 959 A (1) 24,421 D
    Common Stock 06/01/2025 M(1) 206 A (1) 24,627 D
    Common Stock 06/01/2025 M(2) 152 A (2) 24,779 D
    Common Stock 06/01/2025 F(3) 343 D $9.55 24,436 D
    Common Stock 06/01/2025 F(4) 45 D $9.55 24,391 D
    Common Stock 06/02/2025 S(5) 4,698 D $9.5632(6) 19,693 D
    Common Stock 06/03/2025 S(5) 572 D $9.7111(7) 19,121 D
    Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
    (e.g., puts, calls, warrants, options, convertible securities)
    1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
    Restricted Stock Units (1) 05/30/2025 A 100,000 (8) (8) Common Stock 100,000 $0 100,000 D
    Restricted Stock Units (1) 06/01/2025 M(1) 959 (9) (9) Common Stock 959 $0 959 D
    Restricted Stock Units (1) 06/01/2025 M(1) 206 (10) (10) Common Stock 206 $0 1,053 D
    HSKB Phantom Units (2) 06/01/2025 M(2) 152 (11) (11) Common Stock 152 $0 304 D
    Explanation of Responses:
    1. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock.
    2. Reflects Phantom Units of HSKB Funds II, LLC ("HSKB Phantom Units") that upon vesting settled into shares of Common Stock on a one-for-one basis.
    3. Reflects shares withheld to cover the Reporting Person's tax liability in connection with the vesting of the restricted stock units reported herein.
    4. Reflects shares withheld to cover the Reporting Person's tax liability in connection with the vesting of the HSKB Phantom Units reported herein.
    5. The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
    6. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $9.51 to $9.63, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
    7. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $9.65 to $9.75, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
    8. The Reporting Person received an original grant of 100,000 restricted stock units, which vests as follows: (a) 33% on April 1, 2026; and (b) the remainder of the award in equal quarterly installments during the 24 months following April 1, 2026.
    9. The Reporting Person received an original grant of restricted stock units on September 1, 2021, which vest in equal quarterly installments during the 9 months following December 1, 2024.
    10. The Reporting Person received an original grant of restricted stock units on September 1, 2022, which vest in equal quarterly installments during the 21 months following December 1, 2024.
    11. The Reporting Person received an original grant of HSKB Phantom Units on December 1, 2021, which vest in equal quarterly installments during the 12 months following December 1, 2024.
    Remarks:
    /s/ Meredith Weisshaar, as Attorney-in-Fact 06/03/2025
    ** Signature of Reporting Person Date
    Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
    * If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
    ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
    Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
    Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
    Get the next $ZI alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $ZI

    DatePrice TargetRatingAnalyst
    2/26/2025$10.00 → $11.00Underweight → Neutral
    Piper Sandler
    1/7/2025$14.00 → $11.00Overweight → Equal Weight
    Wells Fargo
    1/6/2025$11.00 → $10.00Neutral → Underweight
    Piper Sandler
    12/13/2024Sector Weight → Underweight
    KeyBanc Capital Markets
    11/19/2024$10.30Sector Perform
    Scotiabank
    8/13/2024$15.00 → $9.00Outperform → Neutral
    Daiwa Securities
    8/6/2024Outperform → Mkt Perform
    Raymond James
    8/6/2024$20.00 → $9.50Buy → Neutral
    DA Davidson
    More analyst ratings